It’s Biotech Season! Five Deals to Raise $611 Million.
The Biotech IPO Queue Grows Longer as Five More Companies File (Xconomy)
Alkero Therapeutics, $86 Million.Prevail Therapeutics, $100 Million.Dermavant Sciences, $100 Million.BridgeBio, $225 Million. Atreca,...
Spine Surgery Service Provider Assure Holdings (ARHH) $1.33 Conference Call.
Assure Holdings Sets First Quarter 2019 Conference Call for Wednesday, May 29, 2019, at 11:00 a.m. ET
DENVER, May 21, 2019 (GLOBE NEWSWIRE) -- Assure...
StHealth Capital, Our #1 Ranked Emerging BDC Idea.
Newly Launched Medtech & Biotech BDC Seeking Pre-IPO Stage Investments.
This is easily one of the most exciting fund managers we've come across in a...
Diabasens® to Launch in Europe. Innovus (INNV).
"The product will be launched initially in France, the United Kingdom, Italy, Germany and Spain through our Pan-European Amazon® store, followed by local distributors...
Vaccinex (VCNX) Reports First Quarter 2019 Financial Results and Provides Corporate Update.
Updated interim data from CLASSICAL-Lung study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in June 2019
Enrollment...
Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.
The Company will host a conference call on Wednesday, May 15, 2019 at 4:15 p.m. ET/1:15 p.m. PT to discuss the financial results and...
Innovus (INNV): Twenty-Eight Drugs in Five Years. (San Diego Reader)
(Originally published 4/25/2018)
“I am very steady. I like to work slowly, but surely, to get to my goal.” Thus speaks Bassam Damaj, president and...
Beyonce Tells Uber “Pay me in Stock!”
We all know Beyoncé is brilliant, but this move she made in 2015 may be the absolute ultimate in future planning. Four years ago, Beyoncé...
Adding Innovus Pharma (INNV) $2.50 to Watch List.
Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its lineup.
We're adding...
Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.
CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, provided...
Latest article
OpenWorld: The Contrarian’sCase for OPNW
Why the VerifyMe's (VRME) $0.90 Reverse Merger Deserves a Second Look
LIVE QUOTE
REPORT
$269 Million in Cash and a $178 Million Market Cap. What are the Odds?...
Wife: "Honey, I'm going to the mall, do we have money in the checking?" CEO "Yes, but don't go crazy, we're down to $269...
Former CIA Deputy Director and Chief Technology Officer Joins Sekur Private Data (SWISF).
Strategic Advisory Board Member John T. Lewis, Role Expanded to Chief Technology Officer At Sekur Private Data.
The press release link below list nearly all of...
